Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Today, 4:00 AMCommunity Health Systems, Inc is scheduled to announce earnings today after market close. Analysts expect non-GAAP EPS of $-0.05 and revenue of $3.1B

Peers: HCA UHS THC SEM ACHC HUM EHC CNC SCNX ENSG

| Held by: VTI IWM FNDX VXF IWO VTWO SCHA DFAS IWN PRFZ

Index	RUT	P/E	1.42	EPS (ttm)	2.42	Insider Own	18.23%	Shs Outstand	140.12M	Perf Week	9.90%
Market Cap	476.51M	Forward P/E	-	EPS next Y	-0.30	Insider Trans	0.00%	Shs Float	113.27M	Perf Month	2.99%
Enterprise Value	12.15B	PEG	-	EPS next Q	-0.05	Inst Own	74.18%	Short Float	8.85%	Perf Quarter	2.99%
Income	329.00M	P/S	0.04	EPS this Y	183.61%	Inst Trans	-0.83%	Short Ratio	5.92	Perf Half Y	26.01%
Sales	12.64B	P/B	-	EPS next Y	-134.97%	ROA	2.42%	Short Interest	10.02M	Perf YTD	10.26%
Book/sh	-10.72	P/C	3.87	EPS next 5Y	49.85%	ROE	-	52W High	4.47 -22.96%	Perf Year	1.78%
Cash/sh	0.89	P/FCF	3.33	EPS past 3/5Y	- 8.02%	ROIC	3.42%	52W Low	2.24 53.51%	Perf 3Y	-56.68%
Dividend Est.	-	EV/EBITDA	7.93	Sales past 3/5Y	0.71% -0.89%	Gross Margin	8.57%	Volatility	4.86% 5.39%	Perf 5Y	-62.77%
Dividend TTM	-	EV/Sales	0.96	EPS Y/Y TTM	181.37%	Oper. Margin	8.57%	ATR (14)	0.16	Perf 10Y	-72.01%
Dividend Ex-Date	Dec 13, 2012	Quick Ratio	1.32	Sales Y/Y TTM	0.74%	Profit Margin	2.60%	RSI (14)	61.21	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.47	EPS Q/Q	132.56%	SMA20	6.90%	Beta	2.10	Target Price	3.64
Payout	-	Debt/Eq	-	Sales Q/Q	-0.10%	SMA50	5.64%	Rel Volume	0.57	Prev Close	3.42
Employees	60000	LT Debt/Eq	-	Earnings	Feb 18 AMC	SMA200	5.26%	Avg Volume	1.69M	Price	3.44
IPO	Jun 09, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	613.13% 3.15%	Trades		Volume	972,822	Change	0.58%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-24-25	Downgrade	Jefferies	Buy → Hold	$3
Nov-25-24	Downgrade	Wells Fargo	Equal Weight → Underweight	$5 → $2.50
Nov-22-24	Downgrade	Raymond James	Mkt Perform → Underperform
Mar-06-24	Initiated	Barclays	Equal Weight	$3
Jun-17-22	Initiated	Loop Capital	Hold	$5
Jun-15-22	Downgrade	BofA Securities	Buy → Neutral	$7.50 → $5.50
Mar-29-22	Initiated	Wells Fargo	Equal Weight	$12
Jan-10-22	Resumed	Citigroup	Buy	$16 → $18
Dec-13-21	Upgrade	BofA Securities	Underperform → Buy	$14 → $16
Sep-24-21	Initiated	UBS	Neutral	$12.50
Jul-09-21	Initiated	Seaport Global Securities	Neutral
Jun-10-21	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$12 → $21
May-05-21	Upgrade	Jefferies	Hold → Buy	$11 → $18
Apr-30-21	Upgrade	Credit Suisse	Underperform → Neutral	$4.10 → $10
Feb-20-20	Upgrade	Raymond James	Underperform → Mkt Perform
Nov-16-18	Initiated	UBS	Sell	$2
Mar-23-18	Resumed	Mizuho	Neutral	$4.50
Jan-30-18	Resumed	Wells Fargo	Underperform
Jan-03-18	Initiated	Goldman	Sell
Dec-14-17	Downgrade	JP Morgan	Neutral → Underweight

Show Previous Ratings

Feb-17-26 09:15AM	Ahead of Community Health Systems (CYH) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics (Zacks)
Feb-11-26 07:55AM	Tenet Healthcare (THC) Q4 Earnings and Revenues Surpass Estimates (Zacks) +6.98%
Feb-04-26 11:00AM	Community Health Systems to Webcast Fourth Quarter and Year-End 2025 Conference Call (Business Wire)
Feb-02-26 04:15PM	Community Health Systems, Inc. Announces Partial Redemption of Its 10.875% Senior Secured Notes Due 2032 (Business Wire)
09:00AM	Community Health Systems Completes Sale of Ownership Interests in Clarksville, Tennessee, Hospital to Vanderbilt University Medical Center (Business Wire)
09:00AM	Loading…
09:00AM	Community Health Systems Completes Divestiture of Three Pennsylvania Hospitals to Tenor Health Foundation (Business Wire)
Jan-22-26 09:38AM	Will Community Health's $450M Hospital Divestment Reduce Debt Burden? (Zacks)
Jan-21-26 03:39AM	Community Health Systems to sell Alabama hospital for $450M (Healthcare Dive)
Jan-20-26 04:15PM	Community Health Systems Announces Definitive Agreement to Sell Huntsville, Alabama, Hospital to Huntsville Hospital Health System (Business Wire)
Jan-15-26 03:10PM	Trump unveils his 'Great Healthcare Plan.' Analysts don't expect much of an impact. (MarketWatch)
Jan-09-26 05:12AM	Zacks Industry Outlook Highlights Tenet Healthcare, Universal Health Services and Community Health Systems (Zacks)
Jan-08-26 09:34AM	Hospital Industry Reshaping Under Strain: 3 Stocks Worth Watching (Zacks)
Dec-31-25 11:24AM	Here's Why You Should Retain Community Health Stock for Now (Zacks)
Dec-15-25 04:15PM	Community Health Systems, Inc. Announces Redemptions of Senior Secured Notes (Business Wire)
Dec-11-25 03:59AM	CHS appoints Kevin Hammons as CEO (Healthcare Dive)
04:15PM	Loading…
Dec-10-25 04:15PM	Community Health Systems Appoints Kevin Hammons Chief Executive Officer and Jason Johnson Chief Financial Officer (Business Wire)
Dec-09-25 11:38AM	Community Health Systems Stock Falls 7% Amid Debt & Other Pressures (Zacks)
Dec-04-25 02:17AM	CHS sells lab assets to Labcorp for $194M (Healthcare Dive)
Dec-02-25 04:15PM	Community Health Systems Completes Sale of Select Outreach Laboratory Assets to Labcorp (Business Wire)
Nov-24-25 08:42AM	Is the Options Market Predicting a Spike in Community Health Systems Stock? (Zacks) +8.65%
Nov-07-25 11:36AM	Acadia Q3 Earnings Beat on Growing Volumes, Guidance Lowered (Zacks)
Nov-05-25 11:00AM	Community Health Systems Announces Participation in the 2025 UBS Global Healthcare Conference (Business Wire)
Nov-03-25 04:41AM	CHS inks deal to sell stake in Tennessee hospital to VUMC (Healthcare Dive)
Oct-31-25 10:37AM	VUMC to acquire 80% stake in Tennova Clarksville for $600m (Hospital Management) -6.05%
Oct-30-25 04:30PM	Community Health Systems Announces Definitive Agreement to Sell Ownership Interests in Clarksville, Tennessee, Hospital to Vanderbilt University Medical Center (Business Wire)
01:35PM	Pediatrix Medical's Q3 Test: Can Lower Expenses Drive Earnings? (Zacks)
Oct-27-25 05:49AM	Tenor Health Foundation to acquire three CHS hospitals in US (Hospital Management) +7.56%
02:08AM	CHS promises more hospital divestitures during Q3 earnings call (Healthcare Dive)
Oct-24-25 05:30PM	Community Health Systems Announces Definitive Agreement to Sell Three Pennsylvania Hospitals to Tenor Health Foundation (Business Wire) +25.77%
05:02PM	Community Health Systems Inc (CYH) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
12:34PM	Loading…
12:34PM	Community Health Q3 Earnings Beat on Rising Same-Store Admissions (Zacks)
Oct-23-25 06:00PM	Community Health Systems (CYH) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:25PM	Community Health Systems (CYH) Q3 Earnings and Revenues Beat Estimates (Zacks)
04:25PM	Community Health Systems: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	Community Health Systems, Inc. Announces Third Quarter Ended September 30, 2025 Results (Business Wire)
09:26AM	Community Health Systems Inc (CYH) Q3 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Oct-22-25 09:44AM	What To Expect From Community Health Systems Inc (CYH) Q3 2025 Earnings (GuruFocus.com)
Oct-16-25 10:00AM	Community Health Systems (CYH) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
03:28AM	Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services and Community Health Systems (Zacks)
Oct-15-25 10:18AM	Hospital Market Sneezing, But These 3 Stocks Avoiding the Cold (Zacks)
Oct-09-25 11:00AM	Community Health Systems to Webcast Third Quarter 2025 Conference Call (Business Wire)
Aug-29-25 01:15PM	Is it Time to Hold on to Community Health Systems Stock? (Zacks)
Aug-27-25 11:00AM	Community Health Systems to Participate in the 2025 Wells Fargo Healthcare Conference (Business Wire)
Aug-26-25 08:00AM	Community Health Systems, Inc. Announces Expiration and Final Tender Results of Previously Announced Tender Offer for 5.625% Senior Secured Notes Due 2027 (Business Wire)
Aug-11-25 05:26PM	Community Health Systems, Inc. Announces Consideration for Tender Offer for Its 5.625% Senior Secured Notes Due 2027 (Business Wire)
08:00AM	Community Health Systems, Inc. Announces Early Tender Results for Its 5.625% Senior Secured Notes Due 2027 (Business Wire)
Aug-08-25 06:07AM	CHS to take another stab at selling its Pennsylvania hospital portfolio (Healthcare Dive)
Aug-07-25 12:28PM	Acadia Healthcare Q2 Earnings Beat on Growing Admission Volumes (Zacks)
Aug-01-25 11:40AM	NATIONAL HEALTHCARE COMMUNICATIONS FIRM CONTINUES RAPID GROWTH (PR Newswire) -6.15%
Jul-31-25 09:00AM	Community Health Systems Releases the 2025 Community Impact Report (Business Wire)
Jul-28-25 06:40PM	Community Health Systems, Inc. Announces Increase in Tender Cap for 5.625% Senior Secured Notes Due 2027 (Business Wire) -6.86%
06:35PM	Community Health Systems, Inc. Announces Pricing of Upsized Offering of Senior Secured Notes Due 2034 (Business Wire)
07:50AM	Community Health Systems, Inc. Announces Commencement of Tender Offer for 5.625% Senior Secured Notes Due 2027 (Business Wire)
07:45AM	Community Health Systems, Inc. Announces Offering of $1,500 Million of Senior Secured Notes Due 2034 (Business Wire)
Jul-25-25 08:30AM	Depressed volumes drag CHS second-quarter earnings (Healthcare Dive)
07:48AM	HCA raises annual profit forecast on resilient demand for medical care (Reuters)
03:20AM	Community Health Systems Inc (CYH) Q2 2025 Earnings Call Highlights: Navigating Revenue Growth ... (GuruFocus.com)
Jul-24-25 11:33AM	Community Health Q2 Earnings Miss on Declining Patient Days (Zacks) -25.26%
05:00AM	Labcorp to buy some Community Health assets for $195M (MedTech Dive)
Jul-23-25 05:55PM	Community Health Systems (CYH) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:47PM	Community Health Systems: Q2 Earnings Snapshot (Associated Press Finance)
04:16PM	Tim Hingtgen to Retire as Chief Executive Officer of Community Health Systems (Business Wire)
04:15PM	Community Health Systems, Inc. Announces Second Quarter Ended June 30, 2025 Results (Business Wire)
10:04AM	What To Expect From Community Health Systems Inc (CYH) Q2 2025 Earnings (GuruFocus.com)
05:46AM	Labcorp to acquire select outreach laboratory assets from CHS for $195m (Hospital Management)
Jul-22-25 04:15PM	Community Health Systems Announces Definitive Agreement to Sell Select Outreach Laboratory Assets to Labcorp (Business Wire)
09:37AM	What To Expect From Community Health Systems Inc (CYH) Q2 2025 Earnings (GuruFocus.com)
03:28AM	Zacks Industry Outlook Highlights HCA Healthcare, Tenet Healthcare, Universal Health and Community Health Systems (Zacks)
Jul-21-25 09:23AM	Hospital Market May Be Sick, But These 4 Stocks Are Healthy (Zacks)
Jul-09-25 11:00AM	Community Health Systems to Webcast Second Quarter 2025 Conference Call (Business Wire)
10:19AM	Community Health Systems, Inc. (CYH) Sells Its 80% Stake in Cedar Park Health System to Ascension Health (Insider Monkey)
Jul-01-25 09:00AM	Community Health Systems Completes Divestiture of Cedar Park Regional Medical Center in Texas (Business Wire)
May-23-25 11:30AM	Community Health Systems (CYH) Up 29.2% Since Last Earnings Report: Can It Continue? (Zacks)
May-14-25 11:00AM	Community Health Systems to Participate in 2025 RBC Capital Markets Global Healthcare Conference (Business Wire)
May-07-25 08:00AM	Community Health Systems, Inc. Announces Early Tender Results of Previously Announced Tender Offer for 6.875% Senior Unsecured Notes Due 2028 (Business Wire) +13.10%
May-05-25 07:42AM	Franklin Income SMA Q1 2025 Commentary (Seeking Alpha)
May-01-25 01:40AM	Franklin Income Fund Q1 2025 Commentary (Seeking Alpha)
Apr-29-25 01:21PM	Community Health Q1 Earnings Top on Rising Patient Volumes, Stock Up 8% (Zacks)
05:20AM	Zacks Industry Outlook Highlights HCA Healthcare, Tenet Healthcare, Universal Health Services and Community Health Systems (Zacks)
Apr-28-25 10:58AM	Doctor's Orders: 4 Hospital Stocks to Benefit From Industry Trends (Zacks)
Apr-25-25 04:52AM	Q1 2025 Community Health Systems Inc Earnings Call (Thomson Reuters StreetEvents) -7.29%
Apr-24-25 05:19PM	Community Health Systems, Inc. (CYH) Q1 2025 Earnings Call Transcript (Seeking Alpha) +18.52%
04:48AM	CHS emphasizes divestitures, strong volumes in Q1 earnings (Healthcare Dive)
Apr-23-25 07:30PM	Compared to Estimates, Community Health Systems (CYH) Q1 Earnings: A Look at Key Metrics (Zacks)
06:05PM	Community Health Systems (CYH) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:06PM	Community Health Systems: Q1 Earnings Snapshot (Associated Press Finance)
04:32PM	Community Health Systems, Inc. Announces Commencement of Cash Tender Offer for 6.875% Senior Unsecured Notes Due 2028 (Business Wire)
04:31PM	Community Health Systems, Inc. Announces Sale of $700 Million Aggregate Principal Amount of 10.750% Senior Secured Notes Due 2033 (Business Wire)
04:15PM	Community Health Systems, Inc. Announces First Quarter Ended March 31, 2025 Results (Business Wire)
Apr-21-25 10:00AM	Universal Health Services (UHS) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Apr-16-25 10:25AM	CYH to Sell Stake in Cedar Park Regional to Ascension in $460M Deal (Zacks)
10:00AM	Community Health Systems (CYH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
09:15AM	Ascension to buy out CHS stake in Texas hospital for $460M (Healthcare Dive)
Apr-15-25 04:15PM	Community Health Systems Announces Definitive Agreement to Sell Ownership Interest in Cedar Park Regional Medical Center in Texas (Business Wire)
Apr-09-25 11:00AM	Community Health Systems to Webcast First Quarter 2025 Conference Call (Business Wire) +7.85%
Apr-01-25 09:00AM	Community Health Systems Completes Divestiture of Mooresville, North Carolina Hospital to Duke Health (Business Wire)
Mar-31-25 09:10AM	Community Health Rides on Same-Store Volumes, Streamlining Efforts (Zacks)
09:00AM	Community Health Systems Improves Quality of Life in Local Communities With Doctors' Day Donations and Third Annual Jars of Love Peanut Butter Drive (Business Wire)
Mar-26-25 08:18AM	Fidelity High Income Fund Q4 2024 Review (SeekingAlpha)
07:23AM	Fidelity Capital & Income Fund Q4 2024 Review (SeekingAlpha)

Community Health Systems, Inc. engages in the provision of general and specialized healthcare services and outpatient services. The company was founded in March 1985 and is headquartered in Franklin, TN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Ely James S. III	Director	Dec 31 '25	Option Exercise	0.00	2,882	0	362,281	Dec 31 04:36 PM
Tim Hingtgen	former CEO	Dec 09 '25	Proposed Sale	3.38	66,666	225,664		Dec 09 02:34 PM
Tim Hingtgen	former CEO	Oct 28 '25	Proposed Sale	4.18	532,813	2,226,625		Oct 28 01:23 PM
Brooks Susan W	Director	Jun 01 '25	Option Exercise	0.00	5,894	0	58,100	Jun 02 04:36 PM
Hingtgen Tim	CEO	Mar 01 '25	Option Exercise	0.00	33,600	0	1,267,588	Mar 03 06:06 PM
MEDLEY MARK B	Regional President	Mar 01 '25	Option Exercise	0.00	10,500	0	119,319	Mar 03 06:05 PM
MASON AUSTEN D	Regional President	Mar 01 '25	Option Exercise	0.00	10,500	0	117,500	Mar 03 06:05 PM
CAMPBELL CHAD A	Regional President	Mar 01 '25	Option Exercise	0.00	10,500	0	125,787	Mar 03 06:04 PM
STOCKTON KEVIN A	EVP, Operations & Development	Mar 01 '25	Option Exercise	0.00	10,500	0	142,232	Mar 03 06:04 PM
Pitt Justin D	Pres,Chief Legal&Admin Officer	Mar 01 '25	Option Exercise	0.00	6,300	0	214,416	Mar 03 06:04 PM
Johnson Jason K	SVP & CAO	Mar 01 '25	Option Exercise	0.00	5,250	0	154,593	Mar 03 06:03 PM
HAMMONS KEVIN J	President and CFO	Mar 01 '25	Option Exercise	0.00	25,200	0	589,566	Mar 03 06:03 PM
BENET MIGUEL S	President and CMO	Mar 01 '25	Option Exercise	0.00	3,150	0	58,150	Mar 03 06:02 PM
SMITH WAYNE T	Director	Mar 01 '25	Option Exercise	0.00	30,240	0	5,236,979	Mar 03 06:02 PM
Williams Hubert James	Director	Mar 01 '25	Option Exercise	0.00	36,556	0	161,268	Mar 03 06:01 PM
Hirsch Elizabeth T	Director	Mar 01 '25	Option Exercise	0.00	36,556	0	111,464	Mar 03 05:59 PM
FRY JOHN A	Director	Mar 01 '25	Option Exercise	0.00	36,556	0	218,371	Mar 03 05:58 PM
Ely James S. III	Director	Mar 01 '25	Option Exercise	0.00	36,556	0	359,399	Mar 03 05:58 PM
DINKINS MICHAEL	Director	Mar 01 '25	Option Exercise	0.00	36,556	0	195,220	Mar 03 05:57 PM
CLERICO JOHN A	Director	Mar 01 '25	Option Exercise	0.00	36,556	0	318,168	Mar 03 05:57 PM
Brooks Susan W	Director	Mar 01 '25	Option Exercise	0.00	30,662	0	52,206	Mar 03 05:56 PM
BENET MIGUEL S	President and CMO	Feb 21 '25	Sale	3.52	23,875	84,159	55,000	Feb 25 04:16 PM
Miguel S. Benet	Officer	Feb 21 '25	Proposed Sale	3.52	23,875	84,040		Feb 25 03:09 PM

Open in Screener

GOGO

Gogo Inc

Feb 17 • 04:00PM ET

4.15

-0.02 -0.48 %

Communication Services • Telecom Services • USA • NASD

Peers: VSAT AVGO SATS QCOM IRDM GSAT RKLB NXPI INTC STM

| Held by: IJR VTI IWM VB VXF SPSM IJT IWO VBK XTL

Index	RUT	P/E	-	EPS (ttm)	-0.05	Insider Own	42.79%	Shs Outstand	133.85M	Perf Week	-0.95%
Market Cap	555.50M	Forward P/E	10.13	EPS next Y	0.41	Insider Trans	0.65%	Shs Float	76.58M	Perf Month	-13.18%
Enterprise Value	1.33B	PEG	0.11	EPS next Q	0.02	Inst Own	64.08%	Short Float	27.81%	Perf Quarter	-41.88%
Income	-5.29M	P/S	0.68	EPS this Y	93.40%	Inst Trans	-8.42%	Short Ratio	7.90	Perf Half Y	-65.79%
Sales	817.73M	P/B	5.19	EPS next Y	111.79%	ROA	-0.50%	Short Interest	21.30M	Perf YTD	-10.94%
Book/sh	0.80	P/C	4.16	EPS next 5Y	92.78%	ROE	-6.63%	52W High	16.82 -75.33%	Perf Year	-50.48%
Cash/sh	1.00	P/FCF	11.58	EPS past 3/5Y	-55.51% -	ROIC	-0.53%	52W Low	3.85 7.93%	Perf 3Y	-74.32%
Dividend Est.	-	EV/EBITDA	7.64	Sales past 3/5Y	9.83% 7.55%	Gross Margin	41.28%	Volatility	5.36% 5.63%	Perf 5Y	-70.48%
Dividend TTM	-	EV/Sales	1.63	EPS Y/Y TTM	-110.74%	Oper. Margin	14.99%	ATR (14)	0.26	Perf 10Y	-56.86%
Dividend Ex-Date	-	Quick Ratio	1.40	Sales Y/Y TTM	102.05%	Profit Margin	-0.65%	RSI (14)	39.45	Recom	2.50
Dividend Gr. 3/5Y	- -	Current Ratio	1.74	EPS Q/Q	-117.55%	SMA20	-5.51%	Beta	1.07	Target Price	10.67
Payout	0.00%	Debt/Eq	8.50	Sales Q/Q	122.41%	SMA50	-13.83%	Rel Volume	0.86	Prev Close	4.17
Employees	790	LT Debt/Eq	8.34	Earnings	Feb 27 BMO	SMA200	-56.28%	Avg Volume	2.70M	Price	4.15
IPO	Jun 21, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	-114.29% 0.61%	Trades		Volume	2,292,885	Change	-0.48%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-09-25	Downgrade	William Blair	Outperform → Mkt Perform
Aug-14-25	Resumed	Morgan Stanley	Equal-Weight	$15
Feb-29-24	Resumed	JP Morgan	Neutral	$15 → $11
Nov-01-22	Upgrade	Morgan Stanley	Underweight → Equal-Weight	$14 → $15
Oct-07-21	Upgrade	JP Morgan	Underweight → Neutral	$16
Oct-06-21	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$13 → $14
Apr-08-21	Upgrade	Cowen	Market Perform → Outperform	$12 → $14
Apr-05-21	Upgrade	William Blair	Mkt Perform → Outperform
Feb-23-21	Resumed	Morgan Stanley	Equal-Weight	$13
Feb-01-21	Downgrade	JP Morgan	Neutral → Underweight	$10
Jan-27-21	Downgrade	William Blair	Outperform → Mkt Perform
Sep-09-20	Downgrade	Cowen	Outperform → Market Perform	$5 → $10
Sep-01-20	Reiterated	ROTH Capital	Buy	$8 → $10
May-13-19	Initiated	ROTH Capital	Buy	$10
May-10-19	Upgrade	William Blair	Mkt Perform → Outperform
Apr-18-19	Upgrade	Cowen	Market Perform → Outperform	$4.25 → $7
Jul-24-18	Downgrade	Raymond James	Outperform → Mkt Perform
Jul-17-18	Downgrade	William Blair	Outperform → Mkt Perform
May-18-18	Reiterated	Northland Capital	Under Perform	$3.50 → $1.50
Mar-07-18	Downgrade	Guggenheim	Buy → Neutral

Show Previous Ratings

Feb-17-26 08:42PM	Gogo Inc. (GOGO) Balances Military Wins With Market Challenges (Insider Monkey)
Feb-13-26 10:31AM	ATN International (ATNI) Moves 12.5% Higher: Will This Strength Last? (Zacks)
07:00AM	Gogo to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026 (GlobeNewswire)
Feb-11-26 12:18PM	How Elon Musk's Starlink is fueling growth by tackling terrible airplane wifi (MarketWatch)
Feb-03-26 01:41PM	How & Why SpaceX is Moving the AI Data Center Race to Space (Zacks)
07:00AM	Loading…
Feb-02-26 07:00AM	SDG receives US Air Force Air Mobility Command T-1 certification for RO/RO TRASC capability for C-130 variants (GlobeNewswire)
Jan-30-26 02:58PM	Morgan Stanley Forecasts Low 2026 Growth for Gogo (GOGO) Amid Product Transitions and Industry Tech Debates (Insider Monkey)
Jan-05-26 07:00AM	Gogo issues year-end "report card" on critical new product initiatives. (GlobeNewswire)
Dec-29-25 07:00AM	Gogo confirms next-generation air-to-ground 5G now launched. (GlobeNewswire)
Dec-28-25 12:46PM	William Blair Downgrades Gogo (GOGO) to Market Perform on Starlink Competition and High Debt as AVANCE Migration Stalls Growth (Insider Monkey)
Dec-15-25 11:10PM	Gogo (GOGO) Faces Triple Threat: Elevated Debt, Strained ATG Adds, Intensifying Starlink Competition in Commercial Aviation (Insider Monkey)
Nov-06-25 09:30AM	Here's What Key Metrics Tell Us About Gogo (GOGO) Q3 Earnings (Zacks) -13.07%
08:25AM	Gogo (GOGO) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
07:22AM	Gogo: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Gogo Announces Third Quarter 2025 Results (GlobeNewswire)
07:00AM	Loading…
Nov-03-25 07:00AM	Gogo begins flight testing next-generation air-to-ground connectivity with 5G chip and Gogo AVANCE LX5 and Gogo X3 products. (GlobeNewswire)
Oct-27-25 07:00AM	SD Government, a Gogo Company, receives federal contract to supply airborne communications for US agency (GlobeNewswire)
Oct-23-25 08:15AM	T-Mobile (TMUS) Tops Q3 Earnings and Revenue Estimates (Zacks)
07:00AM	Gogo to Report Third Quarter 2025 Financial Results on November 6, 2025 (GlobeNewswire)
Oct-21-25 08:19PM	Gogo Inc. (GOGO): A Bear Case Theory (Insider Monkey)
Oct-13-25 07:00AM	Hughes and Gogo Celebrate Key FDX and HDX Aviation ESA Milestones (PR Newswire)
07:00AM	Gogo is flying high at NBAA with Gogo Galileo HDX and FDX STCs confirmed, more than 150 HDX antennas shipped, and flight testing of Gogo 5G ATG service planned. (GlobeNewswire)
Oct-07-25 08:12AM	Do You Believe in the Growth Potential of GOGO (GOGO)? (Insider Monkey)
Oct-06-25 07:00AM	Gogo announces first Gogo Galileo FDX STC as ALOFT AeroArchitects receives approval covering Boeing Business Jet BBJ737-series aircraft. (GlobeNewswire)
Oct-02-25 08:30AM	Gogo's 5G ATG Technology Secures Flying Colors in Testing Process (Zacks)
Sep-30-25 07:00AM	Gogo Plane Simple Ka-band terminal certified for Dassault Falcon 7X and 8X aircraft (GlobeNewswire)
Sep-29-25 08:56AM	Bargain Alert on 3 Stocks Investors Have Oversold (MarketBeat) -6.75%
Sep-25-25 07:00AM	Gogo announces 5G ATG will match digital terrestrial performance as testing progresses toward on-wing trials (GlobeNewswire)
Sep-22-25 07:00AM	Gogo announces EASA STC for Gogo Galileo HDX antenna for Bombardier Global aircraft, granted to QCM Design (GlobeNewswire)
Sep-18-25 08:39AM	Gogo Galileo HDX STC approved for Dassault Falcon 2000 family (GlobeNewswire)
09:30AM	Loading…
Aug-07-25 09:30AM	Gogo (GOGO) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) -21.29%
08:15AM	Gogo (GOGO) Q2 Earnings and Revenues Beat Estimates (Zacks)
07:12AM	Gogo: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	Gogo Announces Second Quarter 2025 Results (GlobeNewswire)
Jul-25-25 07:00AM	Gogo to Report Second Quarter 2025 Financial Results on August 7, 2025 (GlobeNewswire)
Jul-21-25 12:15PM	Verizon Communications (VZ) Beats Q2 Earnings and Revenue Estimates (Zacks)
12:15AM	Gogo's New C1 LRU Secures FAA Certification, Paves Way for LTE Upgrade (Insider Monkey)
Jul-15-25 04:27PM	Goldman Spotlights These 3 Stocks in Its Bullish S&P 500 Outlook (MarketBeat)
Jul-09-25 07:00AM	Gogo appoints General (Retired) Mike Minihan, formerly Commander, US Air Mobility Command, to board of directors (GlobeNewswire)
Jun-25-25 09:35AM	Gogo receives STC for Gogo C1-LRU for multiple aircraft types (TipRanks)
Jun-24-25 09:30AM	Gogo confirms STC approved for Gogo C1-LRU for multiple aircraft types to support continued inflight connectivity for legacy ATG customers (GlobeNewswire)
Jun-19-25 10:05AM	Roth increasingly positive about multiple expansion for Gogo (TipRanks)
03:55AM	Gogo (GOGO) Moves 14.9% Higher: Will This Strength Last? (Zacks)
Jun-18-25 07:00AM	Gogo successfully completes first 5G end-to-end call. (GlobeNewswire) +14.92%
Jun-05-25 04:31AM	Zacks Industry Outlook Highlights T-Mobile US, Verizon and Gogo (Zacks)
Jun-04-25 11:09AM	3 Wireless Stocks Likely to Gain Despite Industry Headwinds (Zacks)
May-16-25 12:00PM	All You Need to Know About Gogo (GOGO) Rating Upgrade to Buy (Zacks)
May-12-25 09:29AM	Company News for May 12, 2025 (Zacks) +12.36%
May-10-25 03:04AM	Gogo Inc (GOGO) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Milestones (GuruFocus.com)
May-09-25 09:30AM	Gogo (GOGO) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks) +45.31%
09:00AM	Gogo (GOGO) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
07:57AM	Gogo: Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	Gogo Announces First Quarter 2025 Results (GlobeNewswire)
May-08-25 09:15AM	Stay Ahead of the Game With Gogo (GOGO) Q1 Earnings: Wall Street's Insights on Key Metrics (Zacks)
08:10AM	Cogent Communications (CCOI) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
May-07-25 08:38AM	Gogo confirms PMA for Gogo Galileo FDX, facilitating STC generation for super-midsize and larger aircraft. (GlobeNewswire)
May-05-25 05:57PM	Gogo Inc. (GOGO): Among the Best Breakout Stocks to Buy According to Analysts (Insider Monkey)
Apr-29-25 05:02PM	Gogo confirms outstanding Plane Simple ESA flight test campaign (GlobeNewswire)
Apr-25-25 09:00AM	Gogo to Report First Quarter 2025 Financial Results on May 9th, 2025 (GlobeNewswire)
Apr-22-25 08:05AM	Verizon Communications (VZ) Q1 Earnings and Revenues Beat Estimates (Zacks)
Apr-18-25 09:21AM	Gogo Inc. (GOGO): A Bull Case Theory (Insider Monkey)
Apr-17-25 12:10PM	Why Gogo (GOGO) is Poised to Beat Earnings Estimates Again (Zacks)
Apr-14-25 09:36AM	Are Options Traders Betting on a Big Move in Gogo (GOGO) Stock? (Zacks)
Apr-10-25 11:07AM	Gogo (GOGO) Moves 15.7% Higher: Will This Strength Last? (Zacks) -7.18%
Mar-28-25 05:46PM	Gogo Inc. (GOGO): A Bull Case Theory (Insider Monkey)
10:00AM	Is Gogo Inc. (GOGO) the Best Telecom Stock to Buy According to Hedge Funds? (Insider Monkey)
Mar-20-25 12:05PM	Autodesk in proxy fight, General Mills reports mixed Q3: Morning Buzz (TipRanks)
Mar-19-25 08:00AM	Gogo announces Gulfstream GV and Gulfstream G550 STC for Plane Simple Ka-band terminal (GlobeNewswire) +11.11%
Mar-18-25 12:00PM	Gogo (GOGO) Upgraded to Buy: What Does It Mean for the Stock? (Zacks) +7.11%
Mar-15-25 03:02AM	Gogo Inc (GOGO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Competitive Challenges (GuruFocus.com)
02:22AM	Q4 2024 Gogo Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-14-25 09:30AM	Gogo (GOGO) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:15AM	Gogo (GOGO) Q4 Earnings and Revenues Beat Estimates (Zacks)
07:20AM	Gogo: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Gogo Announces Fourth Quarter and Full Year 2024 Results (GlobeNewswire)
Mar-10-25 04:15PM	Gogo confirms PMA for Gogo Galileo HDX,triggering STC generation for more than thirty aircraft. (GlobeNewswire) +9.55%
Mar-04-25 03:38PM	Gogo Inc. (GOGO): A Bull Case Theory (Insider Monkey)
Feb-26-25 06:20PM	Gogo to Report Fourth Quarter and Full Year 2024 Results on March 14, 2025 (GlobeNewswire)
Feb-20-25 11:00AM	Gogo is unveiled as new brand for the unified Gogo Business Aviation and Satcom Direct companies (GlobeNewswire)
Feb-18-25 03:45PM	GogoSatcom Direct renews three-year preferred supplier agreement with Luxaviation Group for global connectivity solutions (GlobeNewswire)
Feb-06-25 03:44PM	GogoSatcom Direct and Airbus to develop end-to-end cabin connectivity experiences for operators of Airbus Corporate Jets ( ACJ ) (GlobeNewswire)
Dec-05-24 07:05AM	Gogo completes acquisition of Satcom Direct (TipRanks)
Dec-04-24 07:00AM	Gogo Completes Acquisition of Satcom Direct and Announces Leadership Transition (PR Newswire)
Nov-06-24 02:11AM	Gogo Inc (GOGO) Q3 2024 Earnings Call Highlights: Strategic Moves and Revenue Growth Amidst ... (GuruFocus.com) -5.98%
Nov-05-24 09:30AM	Gogo (GOGO) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) +30.23%
08:15AM	Gogo (GOGO) Q3 Earnings and Revenues Beat Estimates (Zacks)
07:13AM	Gogo: Q3 Earnings Snapshot (Associated Press Finance)
07:01AM	Gogo Announces Third Quarter Results (PR Newswire)
Nov-04-24 07:01AM	Gogo Galileo HDX Antenna Passes FAA-Mandated DO-160 Qualification Testing (PR Newswire)
Oct-22-24 05:00PM	Wheels Up Selects Gogo Galileo HDX Fleetwide (PR Newswire)
08:00AM	Textron Aviation Selects Gogo Galileo HDX for Factory Installation on Cessna Citation Longitude, Latitude and Ascend (PR Newswire)
Oct-17-24 01:00PM	Skyservice Announces Development of Gogo Galileo HDX STC for Gulfstream G280 (PR Newswire)
07:01AM	Gogo Inc. to Report Third Quarter 2024 Financial Results on November 5, 2024 (PR Newswire)
Oct-15-24 07:01AM	Gogo Galileo Tour Launches Nationwide (PR Newswire)
Oct-14-24 07:01AM	Gogo Receiving Unprecedented Demand for Gogo Galileo HDX (PR Newswire) +7.01%
Oct-08-24 10:30AM	Heres Why Middle Coast Investing Sold GOGO (GOGO) (Insider Monkey)
Sep-30-24 07:01AM	Gogo to Acquire Satcom Direct (PR Newswire)
Sep-29-24 07:59AM	Gogo Inc. (GOGO): Worst 52-Week Low Stock to Buy Now (Insider Monkey)
Sep-26-24 08:55AM	Gogo Secures 25 STC Contracts for Gogo Galileo HDX (PR Newswire)
Sep-25-24 11:34AM	Is Gogo Inc. (GOGO) The Worst 52-Week Low Stocks to Buy Now According to Short Sellers? (Insider Monkey)

Gogo, Inc. engages in the provision of broadband connectivity services for the business aviation market. The company was founded by Jimmy Ray in 1991 and is headquartered in Broomfield, CO.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
THORNE OAKLEIGH	Executive Chair	Dec 12 '25	Buy	5.34	170,000	907,300	954,098	Dec 16 04:44 PM
TOWNSEND CHARLES C	Director	Nov 18 '25	Buy	6.87	58,763	403,578	137,458	Nov 20 04:01 PM
TOWNSEND CHARLES C	Director	Nov 19 '25	Buy	7.17	31,228	223,948	168,686	Nov 20 04:01 PM
TOWNSEND CHARLES C	Director	Nov 17 '25	Buy	7.07	78,695	556,374	78,695	Nov 18 04:05 PM
TOWNSEND CHARLES C	Director	Nov 14 '25	Buy	7.10	31,314	222,298	1,972,002	Nov 18 04:05 PM
Moore Christopher John	Chief Executive Officer	Aug 08 '25	Buy	12.11	10,000	121,100	10,000	Aug 11 04:01 PM
Begler Michael	EVP, COO	Jun 18 '25	Sale	15.00	107,136	1,607,040	14,454	Jun 20 04:01 PM
Silver (Equity) Holdings, LP	Director	May 22 '25	Sale	11.00	8,500,000	93,500,000	4,174,482	May 27 05:19 PM
Silver (Equity) Holdings, LP	See Remarks	May 22 '25	Proposed Sale	12.81	8,500,000	108,885,000		May 22 08:38 PM
CRANDALL ROBERT L	Director	May 13 '25	Buy	11.84	25,000	296,000	103,934	May 15 04:01 PM
TOWNSEND CHARLES C	Director	Mar 18 '25	Buy	6.74	101,956	687,183	1,940,688	Mar 19 04:01 PM
TOWNSEND CHARLES C	Director	Mar 17 '25	Buy	6.57	98,044	644,149	1,838,732	Mar 19 04:01 PM
THORNE OAKLEIGH	Director	Mar 17 '25	Buy	6.57	45,259	297,352	27,303,395	Mar 18 04:01 PM
THORNE OAKLEIGH	Director	Mar 17 '25	Buy	6.57	30,173	198,237	711,341	Mar 18 04:01 PM

UTHR United Therapeutics Corp daily Stock Chart

Peers: AMGN PFE LLY MRK REGN JNJ BMY VRTX GILD BIIB

| Held by: IJH VTI VB VBR VXF XMHQ MDY IBB IJK XBI

Index	-	P/E	18.28	EPS (ttm)	26.39	Insider Own	3.53%	Shs Outstand	42.90M	Perf Week	1.97%
Market Cap	20.77B	Forward P/E	15.79	EPS next Y	30.55	Insider Trans	-42.29%	Shs Float	41.54M	Perf Month	2.21%
Enterprise Value	18.00B	PEG	1.53	EPS next Q	7.13	Inst Own	95.72%	Short Float	4.16%	Perf Quarter	4.35%
Income	1.27B	P/S	6.64	EPS this Y	11.52%	Inst Trans	1.43%	Short Ratio	4.40	Perf Half Y	54.06%
Sales	3.13B	P/B	3.14	EPS next Y	11.18%	ROA	17.57%	Short Interest	1.73M	Perf YTD	-0.99%
Book/sh	153.61	P/C	7.51	EPS next 5Y	10.32%	ROE	20.04%	52W High	519.99 -7.23%	Perf Year	30.18%
Cash/sh	64.28	P/FCF	18.51	EPS past 3/5Y	34.80% -	ROIC	19.30%	52W Low	266.98 80.70%	Perf 3Y	88.62%
Dividend Est.	-	EV/EBITDA	11.26	Sales past 3/5Y	19.52% 14.71%	Gross Margin	88.59%	Volatility	2.48% 2.22%	Perf 5Y	179.26%
Dividend TTM	-	EV/Sales	5.75	EPS Y/Y TTM	17.16%	Oper. Margin	48.46%	ATR (14)	11.41	Perf 10Y	266.52%
Dividend Ex-Date	-	Quick Ratio	6.07	Sales Y/Y TTM	13.50%	Profit Margin	40.65%	RSI (14)	53.69	Recom	1.60
Dividend Gr. 3/5Y	- -	Current Ratio	6.40	EPS Q/Q	12.12%	SMA20	1.69%	Beta	0.85	Target Price	540.27
Payout	0.00%	Debt/Eq	0.00	Sales Q/Q	6.76%	SMA50	-0.70%	Rel Volume	0.84	Prev Close	473.66
Employees	1305	LT Debt/Eq	0.00	Earnings	Feb 25 BMO	SMA200	22.84%	Avg Volume	392.59K	Price	482.42
IPO	Jun 17, 1999	Option/Short	Yes / Yes	EPS/Sales Surpr.	-2.14% -1.64%	Trades		Volume	332,727	Change	1.85%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-20-25	Initiated	Wells Fargo	Underweight	$414
Sep-26-25	Initiated	RBC Capital Mkts	Outperform	$569
Jun-02-25	Initiated	Cantor Fitzgerald	Overweight	$405
Apr-25-25	Downgrade	Wells Fargo	Overweight → Equal Weight
Apr-21-25	Upgrade	BofA Securities	Underperform → Neutral	$314
Jul-11-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$310 → $321
Feb-12-24	Upgrade	Goldman	Sell → Neutral	$213 → $215
Feb-05-24	Initiated	Leerink Partners	Outperform	$330
Dec-08-23	Initiated	Wells Fargo	Overweight	$309
Dec-06-22	Initiated	UBS	Buy	$320
Dec-05-22	Initiated	Goldman	Sell	$230
Oct-11-22	Initiated	Morgan Stanley	Overweight	$288
Sep-20-22	Reiterated	BofA Securities	Underperform
Sep-19-22	Resumed	Wedbush	Outperform	$263
Feb-11-22	Initiated	BTIG Research	Neutral
Jul-14-21	Upgrade	Argus	Hold → Buy	$205
Apr-26-21	Resumed	Credit Suisse	Outperform	$196
Feb-01-21	Upgrade	H.C. Wainwright	Neutral → Buy	$125 → $195
Sep-14-20	Resumed	JP Morgan	Overweight	$142
Jun-25-20	Reiterated	H.C. Wainwright	Neutral	$85 → $125

Show Previous Ratings

Feb-17-26 05:25PM	USANA Health Sciences (USNA) Q4 Earnings and Revenues Beat Estimates (Zacks)
Feb-11-26 07:00AM	United Therapeutics Corporation to Report Fourth Quarter and Full Year 2025 Financial Results Before the Market Opens on Wednesday, February 25, 2026 (Business Wire)
Feb-06-26 11:04AM	Merck's Subdued 2026 Outlook: What it Means After Q4 Results? (Zacks)
Jan-29-26 10:32PM	A Look Back at Therapeutics Stocks' Q3 Earnings: United Therapeutics (NASDAQ:UTHR) Vs The Rest Of The Pack (StockStory)
Jan-28-26 10:15AM	Merck's Non-Oncology Drugs Q4 Performance: What to Expect (Zacks)
10:33PM	Loading…
Jan-27-26 10:33PM	Therapeutics Stocks Q3 Highlights: United Therapeutics (NASDAQ:UTHR) (StockStory)
Jan-26-26 08:55AM	United Therapeutics Reports Early Success For External Liver Support In Acute Failure (Benzinga)
07:00AM	United Therapeutics Announces Positive Results from Phase 1 Study of miroliverELAP in Patients with Acute Liver Failure (Business Wire)
Jan-22-26 07:00AM	United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors (Business Wire)
Jan-19-26 05:17PM	United Therapeutics Corporation (UTHR): A Bull Case Theory (Insider Monkey)
Jan-16-26 09:45AM	Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term (Zacks)
Jan-15-26 09:40AM	Here's Why United Therapeutics (UTHR) is a Strong Value Stock (Zacks)
Jan-13-26 10:39AM	6 stocks and ETFs that these unsung market heroes see outperforming in 2026 (MarketWatch)
Jan-12-26 03:57PM	6 stocks and ETFs that these unsung market heroes see outperforming in 2026 (MarketWatch)
08:55AM	Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings (Zacks)
11:40AM	Loading…
Jan-08-26 11:40AM	UTHR or MDGL: Which Is the Better Value Stock Right Now? (Zacks)
Jan-07-26 11:40AM	UTHR vs. ZTS: Which Stock Is the Better Value Option? (Zacks)
Jan-05-26 07:00AM	United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-31-25 09:45AM	Here's Why United Therapeutics (UTHR) is a Strong Growth Stock (Zacks)
Dec-30-25 09:40AM	Here's Why United Therapeutics (UTHR) is a Strong Value Stock (Zacks)
Dec-15-25 09:50AM	MRK Gets Positive CHMP Opinion for Expanded Use of Winrevair in PAH (Zacks)
Dec-11-25 09:50AM	Here's Why United Therapeutics (UTHR) is a Strong Momentum Stock (Zacks)
Dec-10-25 11:30AM	Why Is Ironwood (IRWD) Up 24.9% Since Last Earnings Report? (Zacks)
09:40AM	Why United Therapeutics (UTHR) is a Top Value Stock for the Long-Term (Zacks)
Dec-09-25 12:26PM	This Gold Stock Hits A High, With Miner Poised For Huge Swing To Profit (Investor's Business Daily)
09:45AM	Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term (Zacks)
Dec-05-25 11:30AM	Catalyst (CPRX) Up 10% Since Last Earnings Report: Can It Continue? (Zacks)
Dec-04-25 11:30AM	Corcept (CORT) Up 9.2% Since Last Earnings Report: Can It Continue? (Zacks)
11:20AM	Can Merck's New Products Aid Growth as Keytruda LOE Test Looms? (Zacks)
Dec-03-25 07:19AM	Flurry of Bullish Inflows Sends United Therapeutics Higher (FX Empire)
12:04PM	Loading…
Nov-21-25 12:04PM	United Therapeutics Stock, Up 72% Since August, Nears Buy Point Of Rare Base (Investor's Business Daily)
09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Nov-20-25 09:45AM	Here's Why United Therapeutics (UTHR) is a Strong Growth Stock (Zacks)
Nov-19-25 10:52AM	Merck Stock Rise as New PAH Drug Winrevair Meets Goal in Another Study (Zacks)
Nov-12-25 09:50AM	Why United Therapeutics (UTHR) is a Top Momentum Stock for the Long-Term (Zacks)
Nov-09-25 11:02PM	3 Reasons Investors Love United Therapeutics (UTHR) (StockStory)
Nov-05-25 09:40AM	Here's Why United Therapeutics (UTHR) is a Strong Value Stock (Zacks)
12:35AM	The 5 Most Interesting Analyst Questions From United Therapeutics's Q3 Earnings Call (StockStory)
Nov-04-25 09:45AM	Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term (Zacks)
07:00AM	United Therapeutics Corporation to Present at Upcoming Investor Conferences (Business Wire)
Nov-03-25 07:00AM	United Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease (Business Wire)
Oct-30-25 03:48PM	United Therapeutics Corp (UTHR) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com)
11:40AM	MKKGY vs. UTHR: Which Stock Is the Better Value Option? (Zacks)
01:38AM	UTHR Q3 Deep Dive: Clinical Pipeline Advances and High-Dose Product Launches Drive Outlook (StockStory)
Oct-29-25 04:14PM	United Therapeutics Rockets 10% On Growing Enthusiasm For Its Top Drug (Investor's Business Daily) +9.63%
01:11PM	Why Is United Therapeutics (UTHR) Stock Soaring Today (StockStory)
11:24AM	United Therapeutics Q3 Earnings Beat Estimates, Revenues Miss Mark (Zacks)
09:55AM	The Mixed Results For United Therapeutics' Bread-And-Butter Drug (Investor's Business Daily)
09:30AM	Compared to Estimates, United Therapeutics (UTHR) Q3 Earnings: A Look at Key Metrics (Zacks)
08:51AM	United Therapeutics Dips As Bread-And-Butter Drug Comes Up Short (Investor's Business Daily)
07:40AM	United Therapeutics (UTHR) Beats Q3 Earnings Estimates (Zacks)
06:48AM	United Therapeutics (NASDAQ:UTHR) Reports Sales Below Analyst Estimates In Q3 Earnings (StockStory)
06:43AM	United Therapeutics: Q3 Earnings Snapshot (Associated Press Finance)
06:30AM	United Therapeutics Corporation Reports Record Third Quarter 2025 Financial Results (Business Wire)
Oct-27-25 11:17PM	United Therapeutics (UTHR) Reports Q3: Everything You Need To Know Ahead Of Earnings (StockStory)
Oct-24-25 10:05AM	Merck's Non-Oncology Drugs Q3 Performance: What to Expect (Zacks)
Oct-23-25 10:00AM	Analysts Estimate Amneal Pharmaceuticals (AMRX) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-22-25 10:00AM	United Therapeutics (UTHR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Oct-16-25 03:51PM	Jefferies Reiterates Buy Rating on United Therapeutics (UTHR) Amid Patent Case (Insider Monkey)
Oct-15-25 07:00AM	United Therapeutics Corporation to Report Third Quarter 2025 Financial Results Before Market Open on Wednesday, October 29, 2025 (Business Wire)
Oct-13-25 07:00AM	United Therapeutics to Feature Clinical Data at the CHEST 2025 Annual Meeting (Business Wire)
Oct-01-25 10:40AM	Is IPF the Next Big Market Opportunity for United Therapeutics? (Zacks)
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Sep-30-25 04:38PM	Top Stock Reports for NextEra Energy, U.S. Bancorp and Air Products & Chemicals (Zacks)
Sep-26-25 09:46AM	CarMax downgraded, Kenvue upgraded: Wall Street's top analyst calls (The Fly)
Sep-19-25 11:53AM	Can MRK's New Drugs Drive Long-Term Growth Amid Looming Keytruda LOE? (Zacks)
07:00AM	United Therapeutics Corporation to Review Data from the Successful TETON-2 Pivotal Study of Nebulized Tyvaso in Idiopathic Pulmonary Fibrosis (Business Wire)
12:46AM	1 Momentum Stock to Target This Week and 2 We Brush Off (StockStory)
12:03AM	3 Big Reasons to Love United Therapeutics (UTHR) (StockStory)
Sep-16-25 07:00AM	United Therapeutics Corporation to Present at the Bernstein 2nd Annual Healthcare Forum (Business Wire)
Sep-12-25 07:00AM	United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the European Respiratory Society Congress (Business Wire)
Sep-11-25 11:30AM	Theravance Bio (TBPH) Up 9.8% Since Last Earnings Report: Can It Continue? (Zacks)
Sep-10-25 02:46PM	United Therapeutics Price Strength Rating Jumps; Stock Soared 33% Last Week (Investor's Business Daily)
Sep-03-25 01:48PM	UTHR Stock Hits Record High on Tyvaso Meeting IPF Study Goals (Zacks)
09:00AM	Morning Movers: United Therapeutics surges after TETON-2 met primary endpoint (TipRanks)
08:52AM	Pharma, Opendoor, Tesla: Trending Stocks (Yahoo Finance Video)
06:30AM	Lung Disease Breakthrough Boosts United Therapeutics and its Rivals (The Daily Upside)
Sep-02-25 04:09PM	Why United Therapeutics Catapulted 33%, Pulling Insmed, Liquidia With It (Investor's Business Daily) +32.83%
09:34AM	Why United Therapeutics Just Catapulted 35%, Pulling Insmed, Liquidia With It (Investor's Business Daily)
07:00AM	United Therapeutics Corporation Announces TETON-2 Pivotal Study of Tyvaso Meets Primary Endpoint for the Treatment of Idiopathic Pulmonary Fibrosis (Business Wire)
Aug-29-25 11:30AM	Why Is United Therapeutics (UTHR) Up 11.9% Since Last Earnings Report? (Zacks)
07:00AM	United Therapeutics Corporation to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference (Business Wire)
Aug-13-25 12:05AM	5 Insightful Analyst Questions From United Therapeutics's Q2 Earnings Call (StockStory)
Aug-12-25 11:40PM	UTHR Q2 Deep Dive: Tyvaso DPI Drives Growth Amid Pipeline and Competitive Uncertainty (StockStory)
04:06PM	Liquidia Shoots Higher As Yutrepia Launch Kicks Off Amid United Patent Battle (Investor's Business Daily)
10:00AM	Liquidia Shoots Higher, But At-Risk Launch Could Come Back To Haunt It (Investor's Business Daily)
Aug-11-25 04:15PM	3D Systems Reports Second Quarter 2025 Financial Results (GlobeNewswire)
11:32AM	Merck's Narrowed 2025 Sales View: What it Means After Q2 Results? (Zacks)
Aug-01-25 07:00AM	United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program (Business Wire) +7.13%
Jul-31-25 10:15AM	UTHR Q2 Earnings Miss Estimates, Higher Tyvaso Sales Aid Revenues Y/Y (Zacks)
Jul-30-25 09:45AM	Here's Why United Therapeutics (UTHR) is a Strong Growth Stock (Zacks) -5.25%
09:30AM	Compared to Estimates, United Therapeutics (UTHR) Q2 Earnings: A Look at Key Metrics (Zacks)
07:35AM	United Therapeutics (UTHR) Misses Q2 Earnings Estimates (Zacks)
06:46AM	United Therapeutics (NASDAQ:UTHR) Misses Q2 Revenue Estimates (StockStory)
06:36AM	United Therapeutics: Q2 Earnings Snapshot (Associated Press Finance)
06:30AM	United Therapeutics Corporation Reports Record Second Quarter 2025 Financial Results (Business Wire)
Jul-28-25 11:13PM	What To Expect From United Therapeutics's (UTHR) Q2 Earnings (StockStory)
10:00AM	Earnings Preview: Ardelyx (ARDX) Q2 Earnings Expected to Decline (Zacks)
02:07AM	Leerink Partners Remains a Buy on United Therapeutics Corporation (UTHR) With a $408 PT (Insider Monkey)

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MALCOLM JAN	Director	Feb 17 '26	Sale	474.68	50	23,734	220	Feb 17 04:32 PM
JAN MALCOLM	Director	Feb 17 '26	Proposed Sale	474.68	50	23,734		Feb 17 04:19 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Feb 09 '26	Option Exercise	127.65	22,500	2,872,226	14,625	Feb 10 04:30 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Feb 09 '26	Sale	474.65	22,500	10,679,686	0	Feb 10 04:30 PM
MAHON PAUL A	EVP & GENERAL COUNSEL	Feb 05 '26	Option Exercise	146.03	8,300	1,212,049	45,081	Feb 05 04:31 PM
MAHON PAUL A	EVP & GENERAL COUNSEL	Feb 05 '26	Sale	483.25	8,300	4,010,940	36,781	Feb 05 04:31 PM
PAUL MAHON	Officer	Feb 05 '26	Proposed Sale	483.25	8,300	4,010,939		Feb 05 04:03 PM
MALCOLM JAN	Director	Feb 03 '26	Sale	474.23	50	23,712	270	Feb 03 04:31 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Feb 02 '26	Option Exercise	127.65	22,500	2,872,226	14,625	Feb 03 04:31 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Feb 02 '26	Sale	470.95	22,500	10,596,429	0	Feb 03 04:31 PM
JAN MALCOLM	Director	Feb 03 '26	Proposed Sale	474.23	50	23,712		Feb 03 04:03 PM
Michael Benkowitz	Officer	Feb 02 '26	Proposed Sale	469.49	90,000	42,254,100		Feb 02 04:29 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Jan 26 '26	Option Exercise	127.65	22,500	2,872,226	14,625	Jan 28 04:31 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Jan 20 '26	Option Exercise	146.03	7,875	1,149,986	7,875	Jan 28 04:31 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Jan 26 '26	Sale	471.91	22,500	10,617,932	0	Jan 28 04:31 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Jan 20 '26	Sale	464.66	7,875	3,659,182	0	Jan 28 04:31 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Jan 20 '26	Sale	464.66	14,625	6,795,627	0	Jan 28 04:30 PM
MALCOLM JAN	Director	Jan 16 '26	Sale	460.98	50	23,049	320	Jan 20 04:30 PM
JAN MALCOLM	Director	Jan 20 '26	Proposed Sale	460.98	50	23,049		Jan 20 04:02 PM
MAHON PAUL A	EVP & GENERAL COUNSEL	Jan 15 '26	Option Exercise	146.03	8,300	1,212,049	45,081	Jan 15 04:32 PM
MAHON PAUL A	EVP & GENERAL COUNSEL	Jan 15 '26	Sale	469.89	8,300	3,900,122	36,781	Jan 15 04:32 PM
PAUL MAHON	Officer	Jan 15 '26	Proposed Sale	469.89	8,300	3,900,122		Jan 15 04:06 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Jan 12 '26	Option Exercise	127.65	22,500	2,872,226	14,625	Jan 13 05:10 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Jan 12 '26	Sale	479.51	22,500	10,788,876	0	Jan 13 05:10 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Jan 05 '26	Option Exercise	117.76	14,625	1,722,240	14,625	Jan 07 04:31 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Jan 05 '26	Sale	487.38	14,625	7,127,877	0	Jan 07 04:31 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Jan 05 '26	Option Exercise	146.03	7,875	1,149,986	7,875	Jan 07 04:30 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Jan 05 '26	Sale	487.38	7,875	3,838,085	0	Jan 07 04:30 PM
CAUSEY CHRISTOPHER	Director	Jan 06 '26	Option Exercise	119.76	1,000	119,760	5,190	Jan 06 04:31 PM
CAUSEY CHRISTOPHER	Director	Jan 06 '26	Sale	510.00	1,000	510,000	4,190	Jan 06 04:31 PM
MALCOLM JAN	Director	Jan 05 '26	Sale	495.01	50	24,750	370	Jan 06 04:31 PM
CHRISTOPHER CAUSEY	Director	Jan 06 '26	Proposed Sale	510.00	1,000	510,000		Jan 06 04:07 PM
JAN MALCOLM	Director	Jan 06 '26	Proposed Sale	495.01	50	24,750		Jan 06 04:06 PM
CAUSEY CHRISTOPHER	Director	Jan 02 '26	Option Exercise	119.76	1,000	119,760	5,190	Jan 05 04:59 PM
CAUSEY CHRISTOPHER	Director	Jan 02 '26	Sale	500.01	1,000	500,015	4,190	Jan 05 04:59 PM
Michael Benkowitz	Officer	Jan 05 '26	Proposed Sale	496.72	90,000	44,704,800		Jan 05 04:39 PM
MAHON PAUL A	EVP & GENERAL COUNSEL	Jan 02 '26	Option Exercise	146.03	8,300	1,212,049	45,081	Jan 02 04:30 PM
MAHON PAUL A	EVP & GENERAL COUNSEL	Jan 02 '26	Sale	485.43	8,300	4,029,076	36,781	Jan 02 04:30 PM
CHRISTOPHER CAUSEY	Director	Jan 02 '26	Proposed Sale	500.01	1,000	500,015		Jan 02 04:22 PM
PAUL MAHON	Officer	Jan 02 '26	Proposed Sale	485.43	8,300	4,029,076		Jan 02 04:12 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Dec 29 '25	Option Exercise	146.03	7,875	1,149,986	7,875	Dec 30 04:31 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Dec 29 '25	Sale	502.79	22,500	11,312,710	0	Dec 30 04:31 PM
MAHON PAUL A	EVP & GENERAL COUNSEL	Dec 24 '25	Option Exercise	146.03	11,000	1,606,330	47,781	Dec 29 04:31 PM
MAHON PAUL A	EVP & GENERAL COUNSEL	Dec 24 '25	Sale	513.18	11,000	5,644,954	36,781	Dec 29 04:31 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Dec 22 '25	Option Exercise	146.03	7,875	1,149,986	7,875	Dec 29 04:30 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Dec 22 '25	Sale	514.35	22,500	11,572,963	0	Dec 29 04:30 PM
PAUL MAHON	Officer	Dec 24 '25	Proposed Sale	513.18	11,000	5,644,954		Dec 29 09:37 AM
MALCOLM JAN	Director	Dec 23 '25	Sale	512.12	50	25,606	420	Dec 23 04:33 PM
SULLIVAN LOUIS W	Director	Dec 22 '25	Option Exercise	204.93	5,950	1,219,339	5,950	Dec 23 04:33 PM
SULLIVAN LOUIS W	Director	Dec 22 '25	Sale	512.13	5,950	3,047,201	0	Dec 23 04:33 PM
LOUIS WADE SULLIVAN REVOCABLE	Affiliate	Dec 22 '25	Proposed Sale	512.13	5,950	3,047,200		Dec 22 05:13 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Dec 19 '25	Proposed Sale	507.07	2,000	1,014,143		Dec 19 05:39 PM
Thompson Tommy G	Director	Dec 18 '25	Option Exercise	101.80	910	92,638	9,390	Dec 19 04:31 PM
Thompson Tommy G	Director	Dec 18 '25	Sale	500.59	910	455,533	8,480	Dec 19 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Dec 17 '25	Option Exercise	120.26	4,000	481,040	4,130	Dec 19 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Dec 18 '25	Option Exercise	120.26	4,000	481,040	4,130	Dec 19 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Dec 19 '25	Option Exercise	120.26	2,000	240,520	2,130	Dec 19 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Dec 18 '25	Sale	508.87	4,000	2,035,488	130	Dec 19 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Dec 17 '25	Sale	501.04	4,000	2,004,147	130	Dec 19 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Dec 19 '25	Sale	507.07	2,000	1,014,143	130	Dec 19 04:30 PM
TOMMY THOMPSON	Director	Dec 18 '25	Proposed Sale	500.59	910	455,533		Dec 18 04:09 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Dec 18 '25	Proposed Sale	508.87	4,000	2,035,488		Dec 18 04:00 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Dec 17 '25	Proposed Sale	501.04	4,000	2,004,152		Dec 17 04:52 PM
EDGEMOND JAMES	CFO AND TREASURER	Dec 15 '25	Option Exercise	146.03	3,517	513,588	11,659	Dec 16 05:09 PM
EDGEMOND JAMES	CFO AND TREASURER	Dec 15 '25	Sale	495.36	3,517	1,742,193	8,142	Dec 16 05:09 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Dec 15 '25	Option Exercise	120.26	4,000	481,040	4,130	Dec 16 05:08 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Dec 16 '25	Option Exercise	120.26	4,000	481,040	4,130	Dec 16 05:08 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Dec 15 '25	Sale	494.72	4,000	1,978,869	130	Dec 16 05:08 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Dec 16 '25	Sale	493.45	4,000	1,973,820	130	Dec 16 05:08 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Dec 15 '25	Option Exercise	244.05	22,500	5,491,040	14,625	Dec 16 04:33 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Dec 15 '25	Sale	496.30	22,500	11,166,722	0	Dec 16 04:33 PM
PATUSKY CHRISTOPHER	Director	Dec 15 '25	Option Exercise	101.80	1,000	101,800	2,490	Dec 16 04:30 PM
PATUSKY CHRISTOPHER	Director	Dec 15 '25	Sale	495.95	1,000	495,954	1,490	Dec 16 04:30 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Dec 16 '25	Proposed Sale	493.45	4,000	1,973,820		Dec 16 04:01 PM
CHRISTOPHER PATUSKY	Director	Dec 15 '25	Proposed Sale	495.95	1,000	495,954		Dec 15 05:45 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Dec 15 '25	Proposed Sale	494.72	4,000	1,978,869		Dec 15 04:57 PM
MALCOLM JAN	Director	Dec 11 '25	Sale	482.98	50	24,149	470	Dec 12 04:32 PM
MAHON PAUL A	EVP & GENERAL COUNSEL	Dec 11 '25	Option Exercise	146.03	11,000	1,606,330	47,781	Dec 12 04:32 PM
MAHON PAUL A	EVP & GENERAL COUNSEL	Dec 11 '25	Sale	484.67	11,000	5,331,316	36,781	Dec 12 04:32 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Dec 11 '25	Option Exercise	120.26	4,000	481,040	4,130	Dec 12 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Dec 12 '25	Option Exercise	120.26	4,000	481,040	4,130	Dec 12 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Dec 12 '25	Sale	490.70	4,000	1,962,783	130	Dec 12 04:31 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Dec 11 '25	Sale	483.97	4,000	1,935,879	130	Dec 12 04:31 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Dec 12 '25	Proposed Sale	490.70	4,000	1,962,783		Dec 12 04:04 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Dec 11 '25	Proposed Sale	483.97	4,000	1,935,879		Dec 11 04:10 PM
PAUL MAHON	Officer	Dec 11 '25	Proposed Sale	484.67	11,000	5,331,316		Dec 11 04:06 PM
Mesa Nilda	Director	Dec 09 '25	Sale	481.63	187	90,065	5,286	Dec 10 04:54 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Dec 09 '25	Option Exercise	120.26	4,000	481,040	4,130	Dec 10 04:53 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Dec 10 '25	Option Exercise	120.26	4,000	481,040	4,130	Dec 10 04:53 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Dec 10 '25	Sale	480.05	4,000	1,920,191	130	Dec 10 04:53 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Dec 09 '25	Sale	478.30	4,000	1,913,184	130	Dec 10 04:53 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Dec 10 '25	Proposed Sale	480.05	4,000	1,920,190		Dec 10 03:52 PM
NILDA MESA	Director	Dec 09 '25	Proposed Sale	481.63	187	90,065		Dec 09 06:01 PM
EDGEMOND JAMES	CFO AND TREASURER	Dec 08 '25	Option Exercise	146.03	21,000	3,066,630	29,142	Dec 09 04:54 PM
EDGEMOND JAMES	CFO AND TREASURER	Dec 08 '25	Sale	478.60	21,000	10,050,597	8,142	Dec 09 04:54 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Dec 08 '25	Option Exercise	244.05	22,500	5,491,040	14,625	Dec 09 04:31 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Dec 08 '25	Sale	478.58	22,500	10,768,000	0	Dec 09 04:31 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Dec 09 '25	Proposed Sale	478.30	4,000	1,913,184		Dec 09 03:47 PM
ROTHBLATT MARTINE A	FOUNDER, CHAIRPERSON, AND CHIE	Dec 08 '25	Proposed Sale	484.23	4,000	1,936,936		Dec 08 06:25 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Dec 05 '25	Option Exercise	120.26	4,000	481,040	4,130	Dec 08 04:32 PM

CYH

Community Health Systems, Inc

GOGO

Gogo Inc

UTHR

United Therapeutics Corp

Upgrade your FINVIZ experience